Reciprocal regulation of amino acid import and epigenetic state through Lat1 and EZH2

被引:48
作者
Dann, Stephen G. [1 ]
Ryskin, Michael [2 ]
Barsotti, Anthony M. [2 ]
Golas, Jonathon [2 ]
Shi, Celine [2 ]
Miranda, Miriam [2 ]
Hosselet, Christine [2 ]
Lemon, Luanna [2 ]
Lucas, Judy [2 ]
Karnoub, Maha [3 ]
Wang, Fang [2 ]
Myers, Jeremy S. [2 ]
Garza, Scott J. [1 ]
Follettie, Maximillian T. [2 ]
Geles, Kenneth G. [2 ]
Klippel, Anke
Rollins, Robert A. [2 ]
Fantin, Valeria R. [1 ]
机构
[1] Pfizer Oncol Res Unit, San Diego, CA USA
[2] Pfizer Oncol Res Unit, Pearl River, NY USA
[3] Celgene, Summit, NJ USA
关键词
cancer metabolism; methionine cycle; S-adenosylmethionine; SLC7A5; STEM-CELLS; LUNG-CANCER; DIFFERENTIATION; INHIBITION; METABOLISM; EXPRESSION; PHOSPHORYLATION; ACETYLATION; MUTATIONS; POLYCOMB;
D O I
10.15252/embj.201488166
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lat1 (SLC7A5) is an amino acid transporter often required for tumor cell import of essential amino acids (AA) including Methionine (Met). Met is the obligate precursor of S-adenosylmethionine (SAM), the methyl donor utilized by all methyltransferases including the polycomb repressor complex (PRC2)-specific EZH2. Cell populations sorted for surface Lat1 exhibit activated EZH2, enrichment for Met-cycle intermediates, and aggressive tumor growth in mice. In agreement, EZH2 and Lat1 expression are co-regulated in models of cancer cell differentiation and co-expression is observed at the invasive front of human lung tumors. EZH2 knockdown or small-molecule inhibition leads to de-repression of RXR alpha resulting in reduced Lat1 expression. Our results describe a Lat1-EZH2 positive feedback loop illustrated by AA depletion or Lat1 knockdown resulting in SAM reduction and concomitant reduction in EZH2 activity. shRNA-mediated knockdown of Lat1 results in tumor growth inhibition and points to Lat1 as a potential therapeutic target.
引用
收藏
页码:1773 / 1785
页数:13
相关论文
共 50 条
[21]   Molecular characteristics supporting L-Type amino acid transporter 1 (LAT1)-mediated translocation [J].
Karkkainen, Jussi ;
Laitinen, Tuomo ;
Markowicz-Piasecka, Magdalena ;
Montaser, Ahmed ;
Lehtonen, Marko ;
Rautio, Jarkko ;
Gynther, Mikko ;
Poso, Antti ;
Huttunen, Kristiina M. .
BIOORGANIC CHEMISTRY, 2021, 112
[22]   L-Type Amino Acid Transporter 1 (LAT1/Lat1)-Utilizing Prodrugs Can Improve the Delivery of Drugs into Neurons, Astrocytes and Microglia [J].
Huttunen, Johanna ;
Peltokangas, Soile ;
Gynther, Mikko ;
Natunen, Teemu ;
Hiltunen, Mikko ;
Auriola, Seppo ;
Ruponen, Marika ;
Vellonen, Kati-Sisko ;
Huttunen, Kristiina M. .
SCIENTIFIC REPORTS, 2019, 9 (1)
[23]   Prognostic significance of L-type amino acid transporter 1 (LAT1) expression in cutaneous melanoma [J].
Shimizu, Akira ;
Kaira, Kyoichi ;
Kato, Madoka ;
Yasuda, Masahito ;
Takahashi, Ayumi ;
Tominaga, Hideyuki ;
Oriuchi, Noboru ;
Nagamori, Shushi ;
Kanai, Yoshikatsu ;
Oyama, Tetsunari ;
Asao, Takayuki ;
Ishikawa, Osamu .
MELANOMA RESEARCH, 2015, 25 (05) :399-405
[24]   Methionine Commits Cells to Differentiate Into Plasmablasts Through Epigenetic Regulation of BTB and CNC Homolog 2 by the Methyltransferase EZH2 [J].
Zhang, Mingzeng ;
Iwata, Shigeru ;
Hajime, Maiko ;
Ohkubo, Naoaki ;
Todoroki, Yasuyuki ;
Miyata, Hiroko ;
Ueno, Masanobu ;
Hao, He ;
Zhang, Tong ;
Fan, Jie ;
Nakayamada, Shingo ;
Yamagata, Kaoru ;
Tanaka, Yoshiya .
ARTHRITIS & RHEUMATOLOGY, 2020, 72 (07) :1143-1153
[25]   Small molecule inhibitors provide insights into the relevance of LAT1 and LAT2 in materno-foetal amino acid transport [J].
Zaugg, Jonas ;
Huang, Xiao ;
Ziegler, Fabian ;
Rubin, Matthias ;
Graff, Julien ;
Muller, Jennifer ;
Moser-Hassig, Ruedi ;
Powell, Theresa ;
Gertsch, Juerg ;
Altmann, Karl-Heinz ;
Albrecht, Christiane .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (21) :12681-12693
[26]   LAT1 supports mitotic progression through Golgi unlinking in an amino acid transport activity-independent manner [J].
Yanagida, Sakura ;
Yuki, Ryuzaburo ;
Saito, Youhei ;
Nakayama, Yuji .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2024, 300 (10)
[27]   Epigenetic regulation of cancer progression by EZH2: from biological insights to therapeutic potential [J].
Gan, Lu ;
Yang, Yanan ;
Li, Qian ;
Feng, Yi ;
Liu, Tianshu ;
Guo, Weijian .
BIOMARKER RESEARCH, 2018, 6
[28]   Proteomics and phosphoproteomics reveal key regulators associated with cytostatic effect of amino acid transporter LAT1 inhibitor [J].
Okanishi, Hiroki ;
Ohgaki, Ryuichi ;
Okuda, Suguru ;
Endou, Hitoshi ;
Kanai, Yoshikatsu .
CANCER SCIENCE, 2021, 112 (02) :871-883
[29]   Expression of amino acid transporters (LAT1, ASCT2 and xCT) as clinical significance in hepatocellular carcinoma [J].
Namikawa, Masashi ;
Kakizaki, Satoru ;
Kaira, Kyoichi ;
Tojima, Hiroki ;
Yamazaki, Yuichi ;
Horiguchi, Norio ;
Sato, Ken ;
Oriuchi, Noboru ;
Tominaga, Hideyuki ;
Sunose, Yutaka ;
Nagamori, Shushi ;
Kanai, Yoshikatsu ;
Oyama, Tetsunari ;
Takeyoshi, Izumi ;
Yamada, Masanobu .
HEPATOLOGY RESEARCH, 2015, 45 (09) :1014-1022
[30]   The impact of L-type amino acid transporter 1 (LAT1) in human hepatocellular carcinoma [J].
Li, Juan ;
Qiang, Juan ;
Chen, Shu-Fen ;
Wang, Xin ;
Fu, Jing ;
Chen, Yao .
TUMOR BIOLOGY, 2013, 34 (05) :2977-2981